| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6061696 | Annals of Allergy, Asthma & Immunology | 2015 | 7 Pages |
Abstract
Budesonide at 160 μg twice daily through a pMDI was generally well tolerated and significantly improved lung function, symptoms, rescue medication use, and nighttime awakenings vs placebo in children 6 to younger than 12 years with asthma and a demonstrated need for inhaled corticosteroids.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Eli O. MD, David S. MD, GÓ§ran MD, PhD, Tom MS, Michael MD, Kathy MD,